These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34910141)

  • 21. Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence.
    Currie CS; Floyd K; Williams BG; Dye C
    BMC Public Health; 2005 Dec; 5():130. PubMed ID: 16343345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undernutrition as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis.
    Dowdy DW; Steingart KR; Pai M
    PLoS Med; 2011 Aug; 8(8):e1001074. PubMed ID: 21857810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults.
    Sun D; Dorman S; Shah M; Manabe YC; Moodley VM; Nicol MP; Dowdy DW
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):552-8. PubMed ID: 23485389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.
    Alemayehu S; Yigezu A; Hailemariam D; Hailu A
    PLoS One; 2020; 15(7):e0235820. PubMed ID: 32716915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness.
    Arinaminpathy N; Nandi A; Vijayan S; Jha N; Nair SA; Kumta S; Dewan P; Rade K; Vadera B; Rao R; Sachdeva KS
    BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34610905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.
    Pho MT; Swaminathan S; Kumarasamy N; Losina E; Ponnuraja C; Uhler LM; Scott CA; Mayer KH; Freedberg KA; Walensky RP
    PLoS One; 2012; 7(4):e36001. PubMed ID: 22558301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Kapoor S; Gupta A; Shah M
    Int J Tuberc Lung Dis; 2016 Jan; 20(1):85-92. PubMed ID: 26688533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection-a Multicenter Prospective Cohort Analysis.
    Sinha P; Ezhumalai K; Du X; Ponnuraja C; Dauphinais MR; Gupte N; Sarkar S; Gupta A; Gaikwad S; Thangakunam B; Paradkar M; Christopher DJ; Mave V; Viswanathan V; Ellner JJ; Kornfeld H; Horsburgh CR; Padmapriyadarsini C; Gupte A
    Clin Infect Dis; 2024 Jul; 79(1):233-236. PubMed ID: 38652286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.
    Burgos JL; Kahn JG; Strathdee SA; Valencia-Mendoza A; Bautista-Arredondo S; Laniado-Laborin R; Castañeda R; Deiss R; Garfein RS
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):962-8. PubMed ID: 19723375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
    Dowdy DW; Lourenço MC; Cavalcante SC; Saraceni V; King B; Golub JE; Bishai D; Durovni B; Chaisson RE; Dorman SE
    PLoS One; 2008; 3(12):e4057. PubMed ID: 19129940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India.
    Singh M; Sharma A; Bahuguna P; Jyani G; Prinja S
    Indian J Med Res; 2022 Jun; 156(6):705-714. PubMed ID: 37056069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIV.
    Shin H; Jo Y; Chaisson RE; Turner K; Churchyard G; Dowdy DW
    J Int AIDS Soc; 2020 Oct; 23(10):e25629. PubMed ID: 33107219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.
    Castro KG; Marks SM; Chen MP; Hill AN; Becerra JE; Miramontes R; Winston CA; Navin TR; Pratt RH; Young KH; LoBue PA
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):926-33. PubMed ID: 27287646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of lipid-based nutrient supplements (LNS) to improve the nutrient adequacy of general food distribution rations for vulnerable sub-groups in emergency settings.
    Chaparro CM; Dewey KG
    Matern Child Nutr; 2010 Jan; 6 Suppl 1(Suppl 1):1-69. PubMed ID: 20055936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Azadi M; Bishai DM; Dowdy DW; Moulton LH; Cavalcante S; Saraceni V; Pacheco AG; Cohn S; Chaisson RE; Durovni B; Golub JE
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1443-8. PubMed ID: 25517809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undernutrition and the incidence of tuberculosis in India: national and subnational estimates of the population-attributable fraction related to undernutrition.
    Bhargava A; Benedetti A; Oxlade O; Pai M; Menzies D
    Natl Med J India; 2014; 27(3):128-33. PubMed ID: 25668081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.